HROW
Harrow Health IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.23B
P/E Ratio
—
EPS
$-0.38
Beta
0.34
52W High
$54.85
52W Low
$25.53
50-Day MA
$36.27
200-Day MA
$41.32
Dividend Yield
—
Profit Margin
-5.57%
Forward P/E
222.22
PEG Ratio
—
About Harrow Health Inc
Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $268.68M |
| Gross Profit (TTM) | $199.11M |
| EBITDA | $38.87M |
| Operating Margin | -49.90% |
| Return on Equity | -35.40% |
| Return on Assets | 3.14% |
| Revenue/Share (TTM) | $7.24 |
| Book Value | $0.77 |
| Price-to-Book | 42.86 |
| Price-to-Sales (TTM) | 4.58 |
| EV/Revenue | 5.35 |
| EV/EBITDA | 44.18 |
| Quarterly Earnings Growth (YoY) | -10.30% |
| Quarterly Revenue Growth (YoY) | -7.60% |
| Shares Outstanding | $37.28M |
| Float | $28.28M |
| % Insiders | 15.47% |
| % Institutions | 58.91% |
Historical Volatility
HV 10-Day
147.28%
HV 20-Day
104.40%
HV 30-Day
88.59%
HV 60-Day
97.12%
HV Rank
87.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($67.75 target)
8
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026